Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug therapies

Advancing Ophthalmic Drug Therapy, InSite Vision company promotional pubHcation, Alameda, Calif., 1989. [Pg.150]

Sjitgren, Rate Control in Drug Therapy ChurchiU Livingstone, Edinburgh, 1985, pp. 38—47. [Pg.151]

The discovery of the activity of the phenothiazines such as chlorpromazine (44) against schizophrenia pointed the way to drug therapy of diseases of the mind. The intensive... [Pg.72]

Maelicke A., and Albuquerque, E. X. (1996). New approach to drug therapy of Alzheimer s dementia. Drug Discovery Today 1 53-59. [Pg.145]

While advances in the symptomatic drug therapy (summarized below) have certainly improved the lives of many Parkinson patients, the goal of current research is to develop treatments that can prevent, retard or reverse the death of dopaminergic neurons in the substantia nigra pats compacta (and of other neurons involved in the pathogenesis of Parkinson s disease not mentioned in this essay). [Pg.165]

Drug-drug interactions Pharmacokinetic and/or pharmacodynamic interactions Pharmacokinetic and/or pharmacodynamic consequence of multiple drug therapy... [Pg.447]

In clinical life, as outlined in this essay, pharmacokinetics (PK) is used instrumental to improve drug therapy. For this purpose, pharmacokinetics must be presented in general and transmissible terms. The case of kidney failure gives one important example of how disease influences pharmacokinetics and how pharma-cokonetics can be used to produce the same pharmacodynamic effect is such patients. The aim and end... [Pg.954]

The PAR family represents a novel target for drug therapy. Therapeutic approaches with most clinical benefit may rely upon the development of both agonists and antagonists, either of which could be utilised dqiending upon the disease condition [3]. [Pg.1022]

In monitoring drug therapy, the nurse is aware that a... [Pg.14]

Comments stating tiiat the drug looks different from die one previously received, tiiat the drug was just given by another nurse, or tiiat the patient thought tiie primary care provider discontinued die drug therapy. [Pg.19]

The expected outcomes of the patient depend on the reason for administration of penicillin but may include an optimal response to drug therapy, management of common adverse reactions, and an understanding of and compliance with the prescribed drug regimen. [Pg.71]

Rare cases of hemolytic anemia, including fatalities, have been reported with the administration of the cephalosporins. The patient should be monitored for anemia If a patient experiences anemia within 2 to 3 weeks after the start of cephalosporin therapy, drug-induced anemia should be considered. If hemolytic anemia is suspected, the primary health care provider will discontinue the drug therapy. The patient may require blood transfusions to correct tire anemia. Frequent hematological studies may be required. [Pg.79]

Antibiotics are one ot the most commonly administered types ot drug therapy in the home. Any patient taking antibiotics, especially cephalosporins, is susceptible to superintedion. The nurse makes sure the patient knows the signs and symptoms ot superintedion. [Pg.81]

Promoting an Optimal Response to Therapy Monitoring each patient for response to drug therapy and for the appearance of adverse reactions is an integral part of promoting an optimal response to therapy. The nurse immediately reports serious adverse reactions, such as signs and symptoms of a hypersensitivity reaction or superinfection, respiratory difficulty, or a marked drop in blood pressure... [Pg.104]


See other pages where Drug therapies is mentioned: [Pg.129]    [Pg.129]    [Pg.217]    [Pg.122]    [Pg.148]    [Pg.215]    [Pg.216]    [Pg.151]    [Pg.55]    [Pg.448]    [Pg.80]    [Pg.45]    [Pg.2]    [Pg.192]    [Pg.281]    [Pg.4]    [Pg.77]    [Pg.135]    [Pg.144]    [Pg.193]    [Pg.699]    [Pg.699]    [Pg.949]    [Pg.953]    [Pg.954]    [Pg.1082]    [Pg.11]    [Pg.11]    [Pg.27]    [Pg.48]    [Pg.48]    [Pg.51]    [Pg.63]    [Pg.94]    [Pg.95]    [Pg.104]   
See also in sourсe #XX -- [ Pg.55 ]

See also in sourсe #XX -- [ Pg.55 ]

See also in sourсe #XX -- [ Pg.55 ]




SEARCH



Accelerated Access to New Drug Therapies

Alzheimer disease drug therapy

Angina drug therapy

Anti-HIV Drug Combinations Use of Highly Active Antiretroviral Therapy

Antibiotic resistance combined drug therapy

Antibody-dependent drug therapy

Antibody-directed Enzyme Pro-drug Therapy (ADEPT)

Anticancer drugs combination therapy with

Anticoagulant drugs combination therapy

Anticoagulant drugs with antiplatelet therapy

Anticonvulsant drug therapy

Antidepressant drugs (antidepressants maintenance therapy

Antidepressant drugs electroconvulsive therapy

Antiepileptic drug therapy

Antihypertensive drugs individualizing therapy

Antimonial drugs therapy

Antipsychotic drugs therapy

Antipsychotics and Drugs Used in the Therapy of Psychiatric Disorders

Antiretroviral drug therapy

Antiretroviral therapy drug resistance

Antithyroid drug therapy

Antitumour drug therapy

Arrhythmias, cardiac drug therapy

Asthma drug therapy

Atherosclerosis drug therapy

Breast cancer, drug therapy

Cancer drug therapy

Cancer therapy, polymer—drug conjugates

Candida drug therapy

Cardiovascular disease drug therapy

Cardiovascular disorders drug therapies

Chelation therapy drugs used

Chinese traditional medicine drug therapy

Cholesterol drug therapy affecting

Chorea, Huntington drug therapy

Chronic obstructive pulmonary disease drug therapy

Collaborative drug therapy management

Compliance with drug therapy

Cytotoxic Drug Therapy for Diffuse ILD

Depression drug therapy

Drug , anticoagulant therapy

Drug Delivery and Therapy

Drug Delivery for Cancer Therapy

Drug Design of Therapies and Antidotes for Toxins

Drug Therapy (Concepts of Elimination Half-Life and Clearance)

Drug administration hormone replacement therapy

Drug delivery implantation therapy

Drug dose adjustment therapy

Drug targets biopharmaceutical therapies

Drug therapies expensive

Drug therapies management

Drug therapies patient information about

Drug therapies pharmacogenomics-based

Drug therapies safer

Drug therapies therapeutic outcomes

Drug therapies treatment

Drug therapies uncertainties

Drug therapy and psychotherapy of depressions

Drug therapy and psychotherapy of schizophrenia

Drug therapy autonomic nervous system

Drug therapy cardiovascular effects

Drug therapy cardiovascular function

Drug therapy central nervous system

Drug therapy changes

Drug therapy chloramphenicol

Drug therapy consequences, guidelines

Drug therapy development

Drug therapy elderly patients

Drug therapy evaluation

Drug therapy gastrointestinal changes

Drug therapy nursing mothers

Drug therapy outputs

Drug therapy overview

Drug therapy pharmacoeconomic evaluation

Drug therapy pharmacokinetic studies

Drug therapy plan

Drug therapy problem solving

Drug therapy qualifications

Drug therapy renal changes

Drug therapy renal clearance

Drug therapy renal function

Drug therapy zidovudine

Drug therapy, neuropathic pain

Drug therapy, perspectives

Drug therapy, potassium levels

Drug-Alternative Therapy Interactions

Drug-delivery therapy

Drug/gene delivery systems therapy

Dyskinesias, drug-induced therapy

Electroconvulsive therapy drug interactions

Elimination Characteristics During Drug Therapy

Enzyme pro-drug therapy

Ethical issues drug therapy

Extracorporeal Therapy of Patients with Drug Toxicity

Features of Antithyroid Drug and Iodine 131 Therapy for Hyperthyroidism

Gene therapies, drug delivery

Gene therapy drug discovery

Gene therapy pulmonary drug delivery

Herpes simplex virus type 1 thymidine kinase a target for gene-therapy based anticancer drugs

Hyperlipidemia drug therapy

Hyperlipoproteinemia drug therapy

Hypertension drug therapy

INDEX combination drug therapy

Immunosuppressive therapy drug complications

Immunosuppressive therapy drug interactions

Individualized drug therapy

Inflammation, drug therapies

Insulin therapy drug interactions

Interferon therapy drug interactions

Is There Really a Case for Promiscuous Drugs in Anticancer Therapy

Lipoproteins (cont drug therapy affecting

Mucolytic drug therapy

Multi-drug therapy

Multiple drug therapy

Myocardial infarction drug therapy

New drug therapy

Newborn drug therapy

Oncology drugs/therapy

Osteoporosis drug therapy

Pain, drug therapies

Pharmacoproteomics Proteomics and Drug Therapy

Prescription drugs combination therapies

Programmed Packaging A New Drug Delivery System and its Application to Gene Therapy

Pruritus drug therapy

Psychotropic drug therapy

Renal dysfunction drug therapy

Rheumatoid arthritis drug therapy

Schizophrenia drug therapy

Self-assembly drug delivery/targeted therapy

Sepsis drug therapy

Shock drug therapy

Special Concerns for Antiarthritic Drug Therapy in Rehabilitation Patients

Stem cell therapy drug discovery

Sympathomimetic therapy drug interactions

TARGETED DRUG-DELIVERY THERAPY OF TUMORS USING

Targeted drug-delivery therapy

Therapies peptide drugs

Therapy Drug Log

Thyroid hormone therapy drug interactions

Tremor, drug therapy

Tuberculosis drug therapy

Ulcer therapy anticholinergic drugs

Ulcerative colitis drug therapy

Ureterolithiasis-drug-therapy

Urinary tract infections drug therapy

Variation in response to drug therapy

Venous drug therapy

Wrapping as a Biomarker in Personalized Drug Therapy

© 2024 chempedia.info